Scholars@Duke

• Background
• 

  Education, Training, & Certifications

  • M.Med.Sc., Harvard Medical School 2002
  • Research Fellowship in Nephrology, Massachusetts General Hospital 2000 - 2001
  • Clinical Fellowship in Nephrology, Brigham and Women's Hospital 1999 - 2000
  • Internal Medicine Residency, Massachusetts General Hospital 1996 - 1999
  • M.D., State University of New York at Brooklyn 1996
• 

  Duke Appointment History

  • Instructor, Temporary in the Department of Medicine, Medicine, Nephrology, Medicine 2016 - 2017
• Research
• 

  Selected Grants

  • Duke CTSA (KL2) awarded by National Institutes of Health 2018 - 2023
  • Duke CTSA (TL1) awarded by National Institutes of Health 2018 - 2023
  • Pencast Videos to Boost Learning and Interest in Nephrology Among Internal Medicine Residents awarded by American Society of Nephrology 2017 - 2019
  • Vitamin D Catabolism in Chronic Kidney Disease awarded by University of Washington 2016 - 2019
  • FGF-23 and Clinical outcomes in ADPKD awarded by University of Colorado - Denver 2016 - 2018
  • FGF23 and Cardiovascular Disease in CKD (CRIC) awarded by National Institutes of Health 2013 - 2018
  • Role of FGF23 in Mineral Metabolism Across the Spectrum of Chronic Kidney Disease awarded by National Institutes of Health 2013 - 2018
  • Pilot Studies Targeting Mineral Metabolism in CKD awarded by Northwestern University 2013 - 2018
  • Impact of phosphate and FGF23 reduction on intermediate end points in CKD awarded by Northwestern University 2017 - 2018
  • Mentored Patient-Oriented Research in Mineral Metabolism awarded by National Institutes of Health 2012 - 2017
• Publications & Artistic Works
• 

  Selected Publications

  • Journal Articles

    • Isakova, T, Cai, X, Lee, J, Xie, D, Wang, X, Mehta, R, Allen, NB, Scialla, JJ, Pencina, MJ, Anderson, AH, Talierco, J, Chen, J, Fischer, MJ, Steigerwalt, SP, Leonard, MB, Hsu, C-Y, de Boer, IH, Kusek, JW, Feldman, HI, Wolf, M, and Chronic Renal Insufficiency Cohort (CRIC) Study Investigators, . "Longitudinal FGF23 Trajectories and Mortality in Patients with CKD." Journal of the American Society of Nephrology : JASN 29, no. 2 (February 2018): 579-590.  Full Text
    • Mitsnefes, MM, Betoko, A, Schneider, MF, Salusky, IB, Wolf, MS, Jüppner, H, Warady, BA, Furth, SL, and Portale, AA. "FGF23 and Left Ventricular Hypertrophy in Children with CKD." Clinical journal of the American Society of Nephrology : CJASN 13, no. 1 (January 2018): 45-52.  Full Text
    • Batacchi, Z, Robinson-Cohen, C, Hoofnagle, AN, Isakova, T, Kestenbaum, B, Martin, KJ, Wolf, MS, and de Boer, IH. "Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD." Clinical journal of the American Society of Nephrology : CJASN 12, no. 9 (September 2017): 1498-1506.  Full Text
    • Kim, S-J, Cheresh, P, Eren, M, Jablonski, RP, Yeldandi, A, Ridge, KM, Budinger, GRS, Kim, D-H, Wolf, M, Vaughan, DE, and Kamp, DW. "Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosis." American journal of physiology. Lung cellular and molecular physiology 313, no. 1 (July 2017): L16-L26.  Full Text
    • Munoz Mendoza, J, Isakova, T, Cai, X, Bayes, LY, Faul, C, Scialla, JJ, Lash, JP, Chen, J, He, J, Navaneethan, S, Negrea, L, Rosas, SE, Kretzler, M, Nessel, L, Xie, D, Anderson, AH, Raj, DS, Wolf, M, and CRIC Study Investigators, . "Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease." Kidney international 91, no. 3 (March 2017): 711-719.  Full Text
    • Yuen, SN, Kramer, H, Luke, A, Bovet, P, Plange-Rhule, J, Forrester, T, Lambert, V, Wolf, M, Camacho, P, Harders, R, Dugas, L, Cooper, R, and Durazo-Arvizu, R. "Fibroblast Growth Factor-23 (FGF-23) Levels Differ Across Populations by Degree of Industrialization." The Journal of Clinical Endocrinology & Metabolism 101, no. 5 (May 2016): 2246-2253.  Full Text
    • Ali, FN, Josefson, J, Mendez, AJ, Mestan, K, and Wolf, M. "Cord Blood Ferritin and Fibroblast Growth Factor-23 Levels in Neonates." The Journal of Clinical Endocrinology & Metabolism 101, no. 4 (April 2016): 1673-1679.  Full Text
    • Leaf, DE, Christov, M, Jüppner, H, Siew, E, Ikizler, TA, Bian, A, Chen, G, Sabbisetti, VS, Bonventre, JV, Cai, X, Wolf, M, and Waikar, SS. "Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery." Kidney International 89, no. 4 (April 2016): 939-948.  Full Text
    • Wright, CB, Shah, NH, Mendez, AJ, DeRosa, JT, Yoshita, M, Elkind, MS, Sacco, RL, DeCarli, C, Rundek, T, Silverberg, S, Dong, C, and Wolf, M. "Fibroblast Growth Factor 23 Is Associated With Subclinical Cerebrovascular Damage." Stroke 47, no. 4 (April 2016): 923-928.  Full Text
    • Scialla, JJ, and Wolf, M. "When there will never be a randomized controlled trial." Kidney international 88, no. 2 (August 2015): 220-222.  Full Text
    • Wolf, M, and Bushinsky, DA. "Bones and stones, edition 2015." Current Opinion in Nephrology and Hypertension (June 2015): 1-1.  Full Text
    • Wolf, M. "The Biomarker Niche for Fibroblast Growth Factor 23 Testing in CKD." Journal of the American Society of Nephrology 26, no. 1 (January 1, 2015): 7-9.  Full Text
    • Wolf, M. "In Search of the Fountain of Youth." Journal of the American Society of Nephrology 25, no. 10 (October 1, 2014): 2143-2145.  Full Text
    • Wolf, M, and Bushinsky, DA. "Innovations in bones and stones." Current Opinion in Nephrology and Hypertension 22, no. 4 (July 2013): 369-370.  Full Text

Some information on this profile has been compiled automatically from Duke databases and external sources. (Our About page explains how this works.) If you see a problem with the information, please write to Scholars@Duke and let us know. We will reply promptly.